Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue:
Licensing revenue
Expenses:
Research and development		592,768		819,950
General and administrative	1,532,613	2,207,874	3,993,672	4,586,422
Total Expenses	1,532,613	2,800,642	3,993,672	5,406,372
Loss from operations	(1,532,613)	(2,800,342)	(3,993,672)	(5,406,372)
Other income (loss):
Liquidated damages expense	(164,800)		(164,800)
Interest income	4,383	21,302	13,365	112,016
Other income (loss), net	(2,223)	4,782	(5,245)	5,522
Net loss	$ (1,695,253)	$ (2,774,558)	$ (4,150,352)	$ (5,288,834)
Total basic and diluted loss per share	$ (0.04)	$ (0.08)	$ (0.11)	$ (0.16)
Basic and diluted weighted-average shares outstanding	38,472,346	35,195,082	37,069,376	34,070,562